Amy Gershkoff, Sarah South, and Todd Davis

Nov 03, 2016

Ancestry has announced an expansion of its leadership team with the appointments of Amy Gershkoff as chief data officer, Sarah South as vice president of laboratory sciences, and Todd Davis as vice president of global talent. Gershkoff joins Ancestry from Zynga, where she served as chief data officer. Previously, she built and led the customer analytics and insights team and led the global data science team at eBay. South joins Ancestry from 23andMe, where she served as vice president of laboratory services. Previously, South was an associate professor in the department of pathology at the University of Utah. Davis joins Ancestry from Dropbox, where he led global talent acquisition. Prior to Dropbox, he spent four years leading Amazon's global recruiting efforts.

More Like This

Feb 19, 2019

Anthony Schmidt

Circulogene named Anthony Schmidt as its medical director. He will lead the lab's precision medicine initiatives and educate the medical community about the firm's technologies. Schmidt was most recently pathology chair and lab medical director for Mississippi Baptist Healthcare System. 

Feb 19, 2019

Michael McGarrity

MDxHealth has appointed Michael McGarrity as its CEO and member of the firm's board of directors. Prior to MDxHealth, McGarrity served as CEO of Sterilis Medical. Before Sterilis, McGarrity acted as CEO of Nanosphere before it was acquired to Luminex in 2016. Prior to Nanosphere, McGarrity served in leadership roles at Stryker. 

Feb 19, 2019

Andy Watson, Anthony Scarpello

Empire Genomics has appointed Andy Watson as CEO and Anthony Scarpello as chief commercialization officer. Watson was previously CEO at Genturi, a genomics technology startup. He was also chief commercial officer at RainDance Technologies, which was acquired by Bio-Rad Laboratories. Prior to Raindance, he was the vice president of SOLiD sequencing product management at Life Technologies, now part of Thermo Fisher Scientific. He also previously led the capillary electrophoresis sequencing business for Applied Biosystems, which became part of Life Technologies.

Scarpello was promoted from vice president of sales and business development to CCO. He joined Empire Genomics in 2009, and previously held numerous senior management roles with Enzo Life Sciences.

Feb 12, 2019

Emily Balskus, Ami Bhatt, Dean Lee, Jeffrey Rathmell, Noopur Raje, Cameron Turtle

Caribou Biosciences has appointed Emily Balskus, Ami Bhatt, Dean Lee, Jeffrey Rathmell, Noopur Raje, and Cameron Turtle to its scientific advisory board. 

Balskus is a professor of chemistry and chemical biology at Harvard University and an associate member of the Broad Institute of Harvard and MIT. Bhatt is an assistant professor of medicine (hematology) and genetics at Stanford University. Lee is a professor of pediatrics at Nationwide Children's Hospital and Ohio State University, and is also the founding director of the joint cellular therapy and cancer immunotherapy program between the Research Institute at Nationwide Children's Hospital and Ohio State University Comprehensive Cancer Center. Rathmell serves as director of the Vanderbilt Center for Immunobiology and as associate director of the Institute of Infection, Immunology and Inflammation at the Vanderbilt University Medical Center. Raje is a professor of Medicine at Harvard Medical School, director of the Center for Multiple Myeloma, and the Rita Kelley Chair in Oncology at the Massachusetts General Hospital Cancer Center. And Turtle is an associate member at Fred Hutchinson Cancer Research Center and an associate professor at the University of Washington.

The new members will join current scientific advisory board members and Caribou cofounders Jennifer Doudna and Martin Jinek.

Feb 08, 2019

David Anstey

Genomenon has appointed David Anstey as VP of sales and business department. Anstey previously served as VP of sales at Fabric Genomics. Prior to working at Fabric, Anstey held positions at Illumina, YarcData, and IDBS. 

Feb 08, 2019

Siddhartha Mukherjee

SEngine Precision Medicine has appointed Siddhartha Mukherjee to its advisory Board. Mukherjee is the Pulitzer Prize-winning author of the "The Emperor of All Maladies: A Biography of Cancer." Mukherjee is also an assistant professor of medicine and leading cancer researcher at Columbia University.

Feb 08, 2019

Martin Kunz

Twist Bioscience has appointed Martin Kunz as its senior VP of operations. Prior to Twist, he served as president of Eurofins Genomics US. Before serving as president, Kunz acted as chief technology officer at the firm. Prior to Eurofins, he served as chief information officer of Operon Biotechnologies. Kunz has also held a variety of positions at various companies in Switzerland. 

Feb 06, 2019

Susan Siegel

Illumina has named Susan Siegel to its board of directors. Siegel is chief innovation officer at General Electric and CEO of GE Ventures, which invests in startups and commercializes GE's intellectual property. Prior to joining GE, she was a general partner at Mohr Davidow Ventures, where she led investments in personalized medicine, digital health, and life sciences. Siegel was a founding representative member of the National Institutes of Health's National Center for Advancing Translational Sciences and also served on the Precision Medicine Initiative Working Group of the Advisory Committee to the NIH Director.

Feb 05, 2019

Gary Gregory

Perthera has appointed Gary Gregory as the firm's CEO, President, and board member. Gregory's 30 year experience spans several companies and positions, including executive officer roles across firms including Johnson & Johnson, Baxter, Kendal Healthcare, Neuronix, Advanced Dx, NeuroMetrix, and PrimeSource Healthcare. 

Jan 29, 2019

Jonathan Symonds, Sir John Chisholm, John Mattick, Mark Caulfield

Jonathan Symonds has been appointed as chair of Genomics England, replacing Sir John Chisholm, who stepped down this week. Symonds had been a senior non-executive director of the company since 2014.

In addition, John Mattick stepped down as CEO of Genomics England. He is temporarily replaced by Mark Caulfield, the company's chief scientist, who will serve as interim chief executive while a search for a permanent new CEO is ongoing.

Jan 25, 2019

John Steuart, Gail Marcus

John Steuart has resigned from Natera's board of directors. The board has also appointed Gail Marcus as chair of the audit committee. She joined Natera's board in March 2017 and currently serves as chair of the nominating and corporate governance committee.

Jan 25, 2019

Soren Germer, Michael Zody, Ana Bastiani-Posner

Soren Germer has been promoted to senior VP of genome technologies of the New York Genome Center. He previously served as the center's senior scientific director of sequencing operations, and before that, sequencing program manager. In his new role, Germer will lead the activities of the NYGC's sequencing and analysis teams.

Also, Michael Zody has been promoted to scientific director of computational biology of the NYGC, a new role. Zody will continue to provide scientific leadership to the computational biology team as well as lead new grants, foster partnerships, and serve as strategic scientific advisor.

In addition, Ana Bastiani-Posner has joined the NYGC as senior VP of finance and administration. Previously, she held executive finance roles at Allergan, Novartis Pharmaceuticals, and Schering-Plough.

Jan 24, 2019

Greg Thompson

GeneCapture has appointed Greg Thompson as its chief operating officer. Thompson will oversee the product design, commercialization, and medical device approvals for the firm's portable and rapid diagnostic for the point-of-care market. Thompson previously served as VP of design in the medical division and VP of global product design and development at Sanmina. Thompson earned a BSEE degree in computer engineering from North Dakota State University.

Jan 22, 2019

Michael Rasche

Metabolon has appointed Michael Rasche as its president of international business. Rasche will lead the firm's international business activities with a focus on customer and team expansion. Prior to Metabolon, Rasche acted as chief commercial officer at Definiens. Before Definiens, Rasche served as corporate VP of global commercial operations at Ayoxxa. He has also held leadership positions at Dako (now Agilent), Roche, and Bayer Diagnostics in Europe, as well as North and South America.

Jan 18, 2019

TJ Johnson, John Lubniewski

HTG Molecular Diagnostics has announced that TJ Johnson, the firm's current CEO, will assume the role of executive chairman of its board of directors. John Lubniewski, HTG's president and chief operating officer, will succeed Johnson as CEO. In addition, Ann Hanham will assume the role of lead independent director at the end of Q1 2019.

Lubniewski has served as HTG's president and COO since April 2018, joining the firm in 2011 as chief business officer. Before HTG, Lubniewski served in several leadership roles at Ventana, including senior VP and life cycle leader for platforms and clinical assays, as well as head of global marketing. Prior to Ventana, Lubniewski worked at Corning for over a decade in a variety of roles.

New results from the NASA Twins Study indicate that the immune system may rev up when in space, the Washington Post reports.

Kelvin Droegemeier, the new science advisor, spoke at the American Association for the Advancement of Science meeting, Geekwire reports.

In PNAS this week: whole-genome assembly for the white shark, paper-based microfluidic method for detecting the malaria parasite, and more.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.